Medical Liability Reform- Pretrial Screening Panels: S.B. 214 (2005)
Created a pre-trial screening panel requiring all medical liability cases
Created a pre-trial screening panel requiring all medical liability cases go before a three person panel: a judge, an attorney & a health care practitioner of the same or similar specialty as the defendant. SB 214 does not restrict anyone’s right to a jury trial. The panel helps plaintiffs with smaller cases because panel expenses are less. SB 214 required the panel to decide negligence based on a preponderance of evidence (more likely than not), thus encouraging the dropping of non-meritorious cases or quicker settlement of meritorious cases. Only unanimous decisions by the panel are admissible in any future trial. S.B. 214 also created a legislative oversight committee that will look at data over the next few years to determine if the new panel system is working. The bill required liability insurers to report certain data to the New Hampshire Department of Insurance annually.
Latest News
View all news
West Virginia AG Candidates Fail to Sign Transparency Oath
ATRA reports neither candidate for West Virginia Attorney General has signed its transparency oath, writes Chris Dickerson for the West Virginia Record.
Trial Lawyers Treat COVID-19 As Another Feather In Their Caps
ATRA President Tiger Joyce writes about trial lawyers’ latest pet project – business interruption lawsuits against insurance companies in the wake of COVID-19.
Transparency On the Back Burner for West Virginia AG Candidates
ATRA reports West Virginia attorney general candidates’ inaction on transparency code pledge.
Utah AG Candidates Vow to Prioritize Transparency by Signing Pledge
ATRA announces two Utah candidates for attorney general signing its AG transparency code pledge.
Trial Lawyers Delight at Prospect of Congress, White House Flip
A Washington controlled by Democrats would be a bonanza for the trial bar, writes W.J. Kennedy for Legal Newsline.
Judge Managing Opioid Lawsuit Under Scrutiny
ATRA President Tiger Joyce dives into controversies surrounding biases of the federal judge overseeing the nation’s opioid MDL for Inside Sources.